Michael S. Khodadoust

Oncology

875 Blake Wilbur Dr
Palo Alto, CA 94304

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 70 publications

Personalized Circulating Tumor DNA Profiling Enables Superior and Universal Residual Disease Detection in Acute Myeloid Leukemia.

Personalized Circulating Tumor DNA Profiling Enables Superior and Universal Residual Disease Detection in Acute Myeloid Leukemia.

Journal: Blood cancer discovery

Published: May 14, 2026

Phase 1 Trial with Soquelitinib, a Selective ITK Inhibitor for Treatment of Relapsed/Refractory T Cell Lymphomas.

Phase 1 Trial with Soquelitinib, a Selective ITK Inhibitor for Treatment of Relapsed/Refractory T Cell Lymphomas.

Journal: Blood

Published: April 30, 2026

A practical approach to risk stratification of incidental T cell clonality.

A practical approach to risk stratification of incidental T cell clonality.

Journal: Blood advances

Published: April 20, 2026

Clinicopathologic and Molecular Characteristics of Merkel Cell Polyomavirus Positive T-Cell Lymphoproliferative Disorders.

Clinicopathologic and Molecular Characteristics of Merkel Cell Polyomavirus Positive T-Cell Lymphoproliferative Disorders.

Journal: The American journal of surgical pathology

Published: April 14, 2026

Personalized Circulating Tumor DNA (ctDNA) Profiling Enables Superior and Universal Measurable Residual Disease (MRD) Detection in Acute Myeloid Leukemia (AML).

Personalized Circulating Tumor DNA (ctDNA) Profiling Enables Superior and Universal Measurable Residual Disease (MRD) Detection in Acute Myeloid Leukemia (AML).

Journal: medRxiv : the preprint server for health sciences

Published: February 12, 2026

Long-term follow-up of gastrointestinal CAR T-cell lymphoma: homing, clonal expansion, and response to cyclosporine.

Long-term follow-up of gastrointestinal CAR T-cell lymphoma: homing, clonal expansion, and response to cyclosporine.

Journal: Blood

Published: August 27, 2025

Long-term Follow-up of Gastrointestinal CAR T-cell Lymphoma: Homing, Clonal Expansion, and Response to Cyclosporine.

Long-term Follow-up of Gastrointestinal CAR T-cell Lymphoma: Homing, Clonal Expansion, and Response to Cyclosporine.

Journal: Blood

Published: August 27, 2025

'Leukaemic pernio': perniosis-like presentations of chronic lymphocytic leukaemia.

'Leukaemic pernio': perniosis-like presentations of chronic lymphocytic leukaemia.

Journal: Clinical and experimental dermatology

Published: August 08, 2025

Addiction of primary cutaneous γδ T cell lymphomas to JAK/STAT signaling.

Addiction of primary cutaneous γδ T cell lymphomas to JAK/STAT signaling.

Journal: The Journal of clinical investigation

Published: April 15, 2025

Results from an open-label phase 2a study of cerdulatinib, a dual spleen tyrosine kinase/janus kinase inhibitor, in relapsed/refractory peripheral T-cell lymphoma.

Results from an open-label phase 2a study of cerdulatinib, a dual spleen tyrosine kinase/janus kinase inhibitor, in relapsed/refractory peripheral T-cell lymphoma.

Journal: Leukemia & lymphoma

Published: February 08, 2025

Author Correction: Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial.

Author Correction: Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial.

Journal: Nature medicine

Published: November 15, 2024

ASTCT and USCLC clinical practice recommendations for allogeneic stem cell transplant in mycosis fungoides and Sézary syndrome.

ASTCT and USCLC clinical practice recommendations for allogeneic stem cell transplant in mycosis fungoides and Sézary syndrome.

Journal: Journal of the American Academy of Dermatology

Published: September 19, 2024

Showing 1-12 of 70

Last Updated: 09/26/2026